{
    "clinical_study": {
        "@rank": "62227", 
        "arm_group": [
            {
                "arm_group_label": "Blank control group", 
                "arm_group_type": "No Intervention", 
                "description": "A control group of patients is put on a waiting list for  no intervention and  remaining unchanged lifestyle."
            }, 
            {
                "arm_group_label": "intervention group", 
                "arm_group_type": "Active Comparator", 
                "description": "An intervention group of patients is put on a waiting list for acupuncture treatment."
            }
        ], 
        "brief_summary": {
            "textblock": "To determine the efficacy and safety of acupuncture for obesity and overweight people in\n      China."
        }, 
        "brief_title": "Effectiveness and Safety of Acupuncture for Obesity and Over-weight People", 
        "condition": [
            "Obesity", 
            "Overweight"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Overweight"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The individuals is phlegm-dampness constitution and female.\n\n          -  Age is between 18 and 45 years.\n\n          -  BMI is between 24 and 50.\n\n          -  The individuals voluntarily sign the informed consent form.\n\n          -  The individuals live in Harbin City of China.\n\n        Exclusion Criteria:\n\n          -  Secondary obesity, eg:pituitary diseases, hypothalamic disorder, hypothyroidism,\n             pancreatic diseases\uff0chyperadrenocorticism, postmenopausal obesity etc.\n\n          -  The individuals with server cardiovascular and cerebrovascular diseases and cancer.\n\n          -  Having therapy for obesity in the last three months.\n\n          -  The individuals do not adhere to the treatment or are with other treatments.\n\n          -  Female individuals with pregnancy, lactation and  planning a pregnancy in the two\n             months.\n\n          -  Critical patients or patients combined with liver and kidney damage.\n\n          -  Individuals with visual and auditory memory disorders or psychosis."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02108236", 
            "org_study_id": "Acupuncture-Obesity-2014-3"
        }, 
        "intervention": {
            "arm_group_label": "intervention group", 
            "intervention_name": "acupuncture", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "acupuncture", 
            "chinese traditional medicine"
        ], 
        "lastchanged_date": "April 8, 2014", 
        "number_of_arms": "2", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: First Affiliated Hospital of Heilongjiang University of Chinese Medicine", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "body mass index(BMI)", 
            "safety_issue": "No", 
            "time_frame": "2 month after treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02108236"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Heilongjiang University of Chinese Medicine", 
            "investigator_full_name": "Wang Ling Shu", 
            "investigator_title": "the head of institute of chinese medicine and translational science of First Affiliated Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "waist-to-hip ratio (WHR)", 
                "safety_issue": "No", 
                "time_frame": "2 month after treatment"
            }, 
            {
                "measure": "Blood sugar", 
                "safety_issue": "No", 
                "time_frame": "2 month after treatment"
            }, 
            {
                "measure": "Total cholesterol", 
                "safety_issue": "No", 
                "time_frame": "2 month after treatment"
            }, 
            {
                "measure": "Triglycerides", 
                "safety_issue": "No", 
                "time_frame": "2 month after treatment"
            }, 
            {
                "measure": "High-density lipoprotein cholesterol", 
                "safety_issue": "No", 
                "time_frame": "2 month after treatment"
            }, 
            {
                "measure": "Low-density lipoprotein cholesterol", 
                "safety_issue": "No", 
                "time_frame": "2 month after treatment"
            }
        ], 
        "source": "Heilongjiang University of Chinese Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Heilongjiang University of Chinese Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}